Atreca Inc (BCEL)
0.0921
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Atreca Enterprise Value: -17.74M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -17.74M |
| May 30, 2024 | -17.82M |
| May 29, 2024 | -17.86M |
| May 28, 2024 | -17.60M |
| May 24, 2024 | -18.02M |
| May 23, 2024 | -17.82M |
| May 22, 2024 | -17.82M |
| May 21, 2024 | -17.39M |
| May 20, 2024 | -17.74M |
| May 17, 2024 | -17.74M |
| May 16, 2024 | -17.82M |
| May 15, 2024 | -17.66M |
| May 14, 2024 | -17.62M |
| May 13, 2024 | -17.65M |
| May 10, 2024 | -17.82M |
| May 09, 2024 | -17.70M |
| May 08, 2024 | -17.67M |
| May 07, 2024 | -17.71M |
| May 06, 2024 | -17.82M |
| May 03, 2024 | -17.81M |
| May 02, 2024 | -17.58M |
| May 01, 2024 | -17.83M |
| April 30, 2024 | -17.86M |
| April 29, 2024 | -17.90M |
| April 26, 2024 | -18.22M |
| Date | Value |
|---|---|
| April 25, 2024 | -18.00M |
| April 24, 2024 | -18.02M |
| April 23, 2024 | -18.22M |
| April 22, 2024 | -18.02M |
| April 19, 2024 | -18.34M |
| April 18, 2024 | -18.37M |
| April 17, 2024 | -18.32M |
| April 16, 2024 | -18.38M |
| April 15, 2024 | -18.18M |
| April 12, 2024 | -18.18M |
| April 11, 2024 | -18.04M |
| April 10, 2024 | -18.30M |
| April 09, 2024 | -18.42M |
| April 08, 2024 | -18.13M |
| April 05, 2024 | -18.52M |
| April 04, 2024 | -18.61M |
| April 03, 2024 | -18.42M |
| April 02, 2024 | -18.38M |
| April 01, 2024 | -18.22M |
| March 28, 2024 | -18.22M |
| March 27, 2024 | -18.42M |
| March 26, 2024 | -18.22M |
| March 25, 2024 | -18.57M |
| March 22, 2024 | -18.36M |
| March 21, 2024 | -18.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-57.70M
Minimum
Jun 02 2022
590.85M
Maximum
Mar 04 2020
107.79M
Average
7.933M
Median
Enterprise Value Benchmarks
| Catalent Inc | 14.55B |
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -36.22M |
| Total Expenses (Quarterly) | 15.79M |
| EPS Diluted (Quarterly) | -0.92 |
| Earnings Yield | -2.72K% |